(EQNR) Equinor ASA - Overview
Exchange: NYSE •
Country: Norway •
Currency: USD •
Type: Common Stock •
ISIN: US29446M1027
Stock: Oil, Gas, Refining, Renewables, Storage
Total Rating 67
Risk 79
Buy Signal 0.28
| Risk 5d forecast | |
|---|---|
| Volatility | 36.3% |
| Relative Tail Risk | 1.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.28 |
| Alpha | 40.99 |
| Character TTM | |
|---|---|
| Beta | 0.165 |
| Beta Downside | 1.660 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.70% |
| CAGR/Max DD | 0.43 |
EPS (Earnings per Share)
Revenue
Description: EQNR Equinor ASA March 05, 2026
Equinor ASA is an integrated energy company involved in the exploration, production, transport, refining, and marketing of petroleum and other energy sources globally. The integrated oil and gas business model encompasses the entire value chain from upstream exploration and production to downstream refining and distribution.
The company operates through distinct segments including Norwegian, International, and US exploration and production, as well as Marketing, Midstream & Processing, and Renewables. Equinor is also developing carbon capture and storage projects and invests in renewable energy technologies like offshore wind, green hydrogen, and solar power. Energy transition initiatives, such as these, are becoming increasingly common among major oil and gas companies.
Originally incorporated as Statoil ASA in 1972, the company rebranded to Equinor ASA in May 2018. Headquartered in Stavanger, Norway, it trades on the NYSE under the ticker EQNR. For a deeper dive into Equinors financial performance and sector comparisons, consider exploring ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 5.04b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.65 > 1.0 |
| NWC/Revenue: 7.03% < 20% (prev 16.73%; Δ -9.70% < -1%) |
| CFO/TA 0.15 > 3% & CFO 20.03b > Net Income 5.04b |
| Net Debt (28.41b) to EBITDA (38.18b): 0.74 < 3 |
| Current Ratio: 1.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.52b) vs 12m ago -8.30% < -2% |
| Gross Margin: 33.80% > 18% (prev 0.42%; Δ 3338 % > 0.5%) |
| Asset Turnover: 80.49% > 50% (prev 78.16%; Δ 2.33% > 0%) |
| Interest Coverage Ratio: 18.34 > 6 (EBITDA TTM 38.18b / Interest Expense TTM 1.44b) |
Altman Z'' 3.37
| A: 0.06 (Total Current Assets 38.03b - Total Current Liabilities 30.60b) / Total Assets 131.73b |
| B: 0.36 (Retained Earnings 48.03b / Total Assets 131.73b) |
| C: 0.20 (EBIT TTM 26.42b / Avg Total Assets 131.43b) |
| D: 0.44 (Book Value of Equity 40.42b / Total Liabilities 91.23b) |
| Altman-Z'' Score: 3.37 = A |
Beneish M -2.98
| DSRI: 0.60 (Receivables 10.82b/17.46b, Revenue 105.80b/102.50b) |
| GMI: 1.23 (GM 33.80% / 41.59%) |
| AQI: 1.44 (AQ_t 0.25 / AQ_t-1 0.17) |
| SGI: 1.03 (Revenue 105.80b / 102.50b) |
| TATA: -0.11 (NI 5.04b - CFO 20.03b) / TA 131.73b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of EQNR shares?
As of March 05, 2026, the stock is trading at USD 31.58 with a total of 6,154,437 shares traded.
Over the past week, the price has changed by +8.30%, over one month by +19.45%, over three months by +36.93% and over the past year by +48.69%.
Over the past week, the price has changed by +8.30%, over one month by +19.45%, over three months by +36.93% and over the past year by +48.69%.
Is EQNR a buy, sell or hold?
Equinor ASA has received a consensus analysts rating of 3.60.
Therefor, it is recommend to hold EQNR.
- StrongBuy: 1
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EQNR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 24.5 | -22.6% |
| Analysts Target Price | 24.5 | -22.6% |
EQNR Fundamental Data Overview March 04, 2026
P/E Trailing = 16.5309
P/E Forward = 12.3916
P/S = 0.756
P/B = 1.9793
P/EG = 3.5734
Revenue TTM = 105.80b USD
EBIT TTM = 26.42b USD
EBITDA TTM = 38.18b USD
Long Term Debt = 22.90b USD (from longTermDebt, two quarters ago)
Short Term Debt = 5.24b USD (from shortTermDebt, last quarter)
Debt = 33.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 28.41b USD (from netDebt column, last quarter)
Enterprise Value = 94.12b USD (80.01b + Debt 33.44b - CCE 19.33b)
Interest Coverage Ratio = 18.34 (Ebit TTM 26.42b / Interest Expense TTM 1.44b)
EV/FCF = 15.70x (Enterprise Value 94.12b / FCF TTM 6.00b)
FCF Yield = 6.37% (FCF TTM 6.00b / Enterprise Value 94.12b)
FCF Margin = 5.67% (FCF TTM 6.00b / Revenue TTM 105.80b)
Net Margin = 4.77% (Net Income TTM 5.04b / Revenue TTM 105.80b)
Gross Margin = 33.80% ((Revenue TTM 105.80b - Cost of Revenue TTM 70.04b) / Revenue TTM)
Gross Margin QoQ = 25.15% (prev 33.84%)
Tobins Q-Ratio = 0.71 (Enterprise Value 94.12b / Total Assets 131.73b)
Interest Expense / Debt = 1.19% (Interest Expense 398.5m / Debt 33.44b)
Taxrate = 21.0% (US default 21%)
NOPAT = 20.87b (EBIT 26.42b * (1 - 21.00%))
Current Ratio = 1.24 (Total Current Assets 38.03b / Total Current Liabilities 30.60b)
Debt / Equity = 0.83 (Debt 33.44b / totalStockholderEquity, last quarter 40.42b)
Debt / EBITDA = 0.74 (Net Debt 28.41b / EBITDA 38.18b)
Debt / FCF = 4.74 (Net Debt 28.41b / FCF TTM 6.00b)
Total Stockholder Equity = 42.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.84% (Net Income 5.04b / Total Assets 131.73b)
RoE = 11.95% (Net Income TTM 5.04b / Total Stockholder Equity 42.17b)
RoCE = 40.59% (EBIT 26.42b / Capital Employed (Equity 42.17b + L.T.Debt 22.90b))
RoIC = 29.36% (NOPAT 20.87b / Invested Capital 71.07b)
WACC = 4.88% (E(80.01b)/V(113.45b) * Re(6.52%) + D(33.44b)/V(113.45b) * Rd(1.19%) * (1-Tc(0.21)))
Discount Rate = 6.52% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -7.78%
[DCF] Terminal Value 80.82% ; FCFF base≈6.85b ; Y1≈4.50b ; Y5≈2.05b
[DCF] Fair Price = 14.82 (EV 65.38b - Net Debt 28.41b = Equity 36.97b / Shares 2.49b; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -78.71 | EPS CAGR: -16.60% | SUE: 1.14 | # QB: 1
Revenue Correlation: -68.96 | Revenue CAGR: -9.04% | SUE: 0.16 | # QB: 0
EPS current Year (2026-12-31): EPS=2.58 | Chg7d=+0.000 | Chg30d=-0.034 | Revisions Net=-1 | Growth EPS=+4.6% | Growth Revenue=-7.1%
EPS next Year (2027-12-31): EPS=2.83 | Chg7d=+0.000 | Chg30d=-0.020 | Revisions Net=+0 | Growth EPS=+9.4% | Growth Revenue=-1.2%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 1.9% (Discount Rate 7.9% - Earnings Yield 6.0%)
[Growth] Growth Spread = -3.1% (Analyst -1.2% - Implied 1.9%)
P/E Forward = 12.3916
P/S = 0.756
P/B = 1.9793
P/EG = 3.5734
Revenue TTM = 105.80b USD
EBIT TTM = 26.42b USD
EBITDA TTM = 38.18b USD
Long Term Debt = 22.90b USD (from longTermDebt, two quarters ago)
Short Term Debt = 5.24b USD (from shortTermDebt, last quarter)
Debt = 33.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 28.41b USD (from netDebt column, last quarter)
Enterprise Value = 94.12b USD (80.01b + Debt 33.44b - CCE 19.33b)
Interest Coverage Ratio = 18.34 (Ebit TTM 26.42b / Interest Expense TTM 1.44b)
EV/FCF = 15.70x (Enterprise Value 94.12b / FCF TTM 6.00b)
FCF Yield = 6.37% (FCF TTM 6.00b / Enterprise Value 94.12b)
FCF Margin = 5.67% (FCF TTM 6.00b / Revenue TTM 105.80b)
Net Margin = 4.77% (Net Income TTM 5.04b / Revenue TTM 105.80b)
Gross Margin = 33.80% ((Revenue TTM 105.80b - Cost of Revenue TTM 70.04b) / Revenue TTM)
Gross Margin QoQ = 25.15% (prev 33.84%)
Tobins Q-Ratio = 0.71 (Enterprise Value 94.12b / Total Assets 131.73b)
Interest Expense / Debt = 1.19% (Interest Expense 398.5m / Debt 33.44b)
Taxrate = 21.0% (US default 21%)
NOPAT = 20.87b (EBIT 26.42b * (1 - 21.00%))
Current Ratio = 1.24 (Total Current Assets 38.03b / Total Current Liabilities 30.60b)
Debt / Equity = 0.83 (Debt 33.44b / totalStockholderEquity, last quarter 40.42b)
Debt / EBITDA = 0.74 (Net Debt 28.41b / EBITDA 38.18b)
Debt / FCF = 4.74 (Net Debt 28.41b / FCF TTM 6.00b)
Total Stockholder Equity = 42.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.84% (Net Income 5.04b / Total Assets 131.73b)
RoE = 11.95% (Net Income TTM 5.04b / Total Stockholder Equity 42.17b)
RoCE = 40.59% (EBIT 26.42b / Capital Employed (Equity 42.17b + L.T.Debt 22.90b))
RoIC = 29.36% (NOPAT 20.87b / Invested Capital 71.07b)
WACC = 4.88% (E(80.01b)/V(113.45b) * Re(6.52%) + D(33.44b)/V(113.45b) * Rd(1.19%) * (1-Tc(0.21)))
Discount Rate = 6.52% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -7.78%
[DCF] Terminal Value 80.82% ; FCFF base≈6.85b ; Y1≈4.50b ; Y5≈2.05b
[DCF] Fair Price = 14.82 (EV 65.38b - Net Debt 28.41b = Equity 36.97b / Shares 2.49b; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -78.71 | EPS CAGR: -16.60% | SUE: 1.14 | # QB: 1
Revenue Correlation: -68.96 | Revenue CAGR: -9.04% | SUE: 0.16 | # QB: 0
EPS current Year (2026-12-31): EPS=2.58 | Chg7d=+0.000 | Chg30d=-0.034 | Revisions Net=-1 | Growth EPS=+4.6% | Growth Revenue=-7.1%
EPS next Year (2027-12-31): EPS=2.83 | Chg7d=+0.000 | Chg30d=-0.020 | Revisions Net=+0 | Growth EPS=+9.4% | Growth Revenue=-1.2%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 1.9% (Discount Rate 7.9% - Earnings Yield 6.0%)
[Growth] Growth Spread = -3.1% (Analyst -1.2% - Implied 1.9%)